Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LASA | NSE
-1.30
-4.57%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
27.12
28.50
28.50
26.99
Lasa Supergenerics Limited engages in the research manufacture and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole toldimphos sodium cyromazine albendazole riclabendazole rafoxanide ornidazole ricobendazole oxfendazole closantel base closantel sodium nitroxynil halquinol and oxyclozanide as well as 26-diiodo-4-nitrophenol; and other API products such as anthelmintics. The company also provides animal feed ingredients including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
51.4%1 month
73.1%3 months
60.4%6 months
53.6%-
-
1.55
0.23
0.15
-13.02
1.61
-
-9.17M
1.36B
16.25M
-
-3.23
224.80
0.90
-20.22
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
6.50
Range1M
8.44
Range3M
11.69
Rel. volume
0.24
Price X volume
1.58M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -13.02 | - | Cheaper |
Ent. to Revenue | 1.61 | - | Cheaper |
PE Ratio | - | 47.84 | - |
Price to Book | 1.55 | 6.55 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 60.39 | - | Riskier |
Debt to Equity | 0.23 | 0.34 | Cheaper |
Debt to Assets | 0.15 | 0.17 | Par |
Market Cap | 1.36B | - | Emerging |